AN2 Therapeutics Inc
(NAS:ANTX)
$
5.1
+0.050 (+0.99%)
Market Cap: 192.46 Mil
Enterprise Value: 114.07 Mil
PE Ratio: 0
PB Ratio: 2.44
GF Score: 26/100 Recent Filings
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Financials
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Ownership
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Material News Releases
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Proxy
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Others
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||